Skip to content

Autolus Therapeutics plc

AUTL· NasdaqCore metricsCIK 1730463

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -2.85%
Market cap
$318.28M
266.34M shares
Filings
343
$41.24M
Q3 2026+644.9% FY25 yoy
-$55.09M
Q3 2026N/M FY25 yoy
-$43.54M
Q3 2026N/M FY25 yoy
-$113.77M
Q3 2026derivedN/M FY25 yoy
-$0.21
Q3 2026N/M FY25 yoy
$245.41M
Q3 2026−54.2% FY25 yoy
$318.28M
—
2.3×
11.6×
-56.62%
—

Twelve months to Sep 30, 2026 · derived

Price

$1.2020.60%$0.31past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$75.39MFY 2025
$75.39M0FY 2016FY 2017FY 2018FY 2019FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$75,388,000reported
FY 20242024-12-31$10,120,000reported
FY 20232023-12-31$1,698,000reported
FY 20192019-12-31$2,908,000reported
FY 20182018-09-30$1,407,000reported
FY 20172017-09-30$1,693,000reported
FY 20162016-09-30$1,212,000reported

Segments

Long-lived assets by Geography, FY2022 to FY2025FY2022United Kingdom · FY2022 · $56.38MUnited States · FY2022 · $2.04MFY2023United Kingdom · FY2023 · $94.03MUnited States · FY2023 · $1.62MFY2024United Kingdom · FY2024 · $104.16MUnited States · FY2024 · $891.00KFY2025United Kingdom · FY2025 · $127.66MUnited States · FY2025 · $455.00KEurope · FY2025 · $390.00K
LineFY2025ShareChange
United Kingdom$127.66M99%+22.6%
United States$455.00K0.4%−48.9%
Europe$390.00K0.3%—
Total$128.50M

From the 10-K filed Mar 27, 2026AUTL

Biological products, except diagnostic substances

Autolus Therapeutics plc is the 34th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Autolus Therapeutics plc · CIK 1730463 · Engraved from SEC EDGAR